Loading market dashboard
RenovoRx, Inc.
RNXTHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
RenovoRx, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $259.30M | $120.67M - $420.91M | $51.86M | $1.637 | 1 |
| Dec 2029 | $123.45M | $57.45M - $200.38M | $24.69M | $0.63 | 2 |
| Dec 2028 | $38.24M | $17.80M - $62.07M | $7.65M | $0.063 | 3 |
| Dec 2027 | $12.29M | $4.01M - $20.58M | $2.46M | -$0.145 | 3 |
| Dec 2026 | $3.21M | $1.49M - $5.20M | $641.2K | -$0.295 | 3 |
| Dec 2025 | $1.30M | $1.18M - $1.43M | $260.9K | -$0.202 | 3 |
| Dec 2024 | $662.0K | $308.1K - $1.07M | $132.4K | -$0.39 | 2 |